You have 9 free searches left this month | for more free features.

Estrogen Free Pill

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cystic Fibrosis, Hypoestrogenism Trial in Baltimore (Transdermal estrogen, Placebo patch, Progesterone)

Not yet recruiting
  • Cystic Fibrosis
  • Hypoestrogenism
  • Transdermal estrogen
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins
Jan 19, 2023

Estrogen Deficiency, Cardiovascular Disease (CVD), Hypothalamic Amenorrhea Trial in Los Angeles (17beta Estradiol, Transdermal

Active, not recruiting
  • Estrogen Deficiency
  • +2 more
  • 17beta Estradiol
  • +3 more
  • Los Angeles, California
    Cedars-Sinai Barbra Streisand Women's Heart Center
May 3, 2022

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

Eating Disorders, Hypoestrogenemia Trial in Boston (17-ß estradiol transdermal patches with cyclic progesterone, Placebo patch

Recruiting
  • Eating Disorders
  • Hypoestrogenemia
  • 17-β estradiol transdermal patches with cyclic progesterone
  • Placebo patch and pill
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 3, 2021

Overweight and Obesity, Insulin Resistance Trial in Columbia (Placebo - Cap, Amiloride Pill)

Recruiting
  • Overweight and Obesity
  • Insulin Resistance
  • Placebo - Cap
  • Amiloride Pill
  • Columbia, Missouri
    University of Missouri Hospital and Clinics
May 19, 2022

Hypertension Trial in China (Fixed [Per/Ind/Aml], Free [Per/Ind + Aml])

Completed
  • Hypertension
  • Fixed [Per/Ind/Aml]
  • Free [Per/Ind + Aml]
  • Beijing, Beijing, China
  • +41 more
Apr 18, 2023

Endometroid Endometrial Cancer Trial in Baltimore (Alpelisib Pill, Fulvestrant injection)

Not yet recruiting
  • Endometroid Endometrial Cancer
  • Alpelisib Pill
  • Fulvestrant injection
  • Baltimore, Maryland
    Johns Hopkins Medicine
Dec 7, 2021

Menopause, Hot Flashes Trial in Chicago (Soy Phytoestrogen, Estradiol, Medroxyprogesterone Acetate (MPA))

Completed
  • Menopause
  • Hot Flashes
  • Soy Phytoestrogen
  • +4 more
  • Chicago, Illinois
    University of Illinois at Chicago
Nov 12, 2020

Effect of Oestrogen on Musculoskeletal Outcomes

Recruiting
  • Contraception
  • +2 more
    • Camberley, Surrey, United Kingdom
      Army Health and Performance Laboratory
    Oct 18, 2022

    PTSD Trial in Philadelphia (Estradiol, Placebo oral tablet)

    Recruiting
    • PTSD
    • Philadelphia, Pennsylvania
      University of Pennsylvania Perelman School of Medicine
    Jan 30, 2023

    Contraception Trial in San Martino (Female Contraceptive)

    Recruiting
    • Contraception
    • Female Contraceptive
    • San Martino, Genova, Italy
      IRCCS Ospedale Policlinico
    Sep 28, 2023

    Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

    Recruiting
    • Metastatic Breast Cancer
    • Anchorage, Alaska
    • +58 more
    Jan 6, 2023

    Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Manchester, Greater Manchester, United Kingdom
    • +20 more
    Aug 5, 2022

    Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

    Recruiting
    • Metastatic Breast Cancer
    • Enobosarm & Abemaciclib Combo
    • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
    • Chandler, Arizona
    • +29 more
    Feb 1, 2023

    Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Springfield, Massachusetts
    • +2 more
    Nov 1, 2022

    Contraception Trial in Sacramento, Portland (Norgestrel 0.075 mg)

    Completed
    • Contraception
    • Norgestrel 0.075 mg
    • Sacramento, California
    • +1 more
    Jun 2, 2021

    Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • Low Grade Serous Adenocarcinoma of Ovary
    • Letrozole tablets
    • carboplatin AUC 5 and paclitaxel 175 mg/m2
    • Brescia, BS, Italy
    • +1 more
    Oct 26, 2022

    Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)

    Recruiting
    • Endometriosis
    • simvastatin 10mg
    • +2 more
    • New Haven, Connecticut
      The John B. Pierce Laboratory
    Dec 8, 2022

    Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

    Not yet recruiting
    • Hormone-receptor-positive Breast Cancer
    • +3 more
    • Aromatase inhibitor
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Apr 5, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Prognostic Stage IV Breast Cancer AJCC v8
    • Pembrolizumab
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Contraception Trial in Aurora (Desogestrel and Ethinyl Estradiol Tablets)

    Recruiting
    • Contraception
    • Desogestrel and Ethinyl Estradiol Tablets
    • Aurora, Colorado
      University of Colorado Denver
    Mar 8, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Sherbrooke, Quebec, Canada
      Centre de recherche du CHUS
    Oct 31, 2022